KJHP
BEAM icon

K.J. Harrison & Partners’s Beam Therapeutics BEAM Stock Holding History

K.J. Harrison & Partners’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,497
Closed -$450K – 247
2022
Q4 		$450K Buy
8,497
+2,000
+31% +$89.6K 0.09% 164
2022
Q3 		$310K Sell
6,497
-10,000
-61% -$570K 0.11% 131
2022
Q2 		$639K Hold
16,497
– – 0.17% 116
2022
Q1 		$945K Buy
16,497
+5,000
+43% +$328K 0.15% 129
2021
Q4 		$918K Buy
11,497
+7
+0.1% +$599 0.13% 167
2021
Q3 		$1M Sell
11,490
-3,000
-21% -$301K 0.15% 159
2021
Q2 		$1.87M Buy
14,490
+6,040
+71% +$481K 0.2% 108
2021
Q1 		$676K Buy
+8,450
New +$804K 0.1% 181

Other funds holding BEAM

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

K.J. Harrison & Partners's BEAM Position: Q1 2023 in Review

K.J. Harrison & Partners sold out of Beam Therapeutics (BEAM) in Q1 2023, closing a stake of 8,497 shares — an estimated $450K sold.

K.J. Harrison & Partners first reported a position in BEAM in Q1 2021 and held it in 8 quarters. The position peaked at $1.87M in Q2 2021. 206 funds tracked by Wall St. Rank hold BEAM as of Q1 2023.

  • K.J. Harrison & Partners reported no remaining Beam Therapeutics position as of Q1 2023 after selling out during the quarter.
  • K.J. Harrison & Partners sold 8,497 Beam Therapeutics shares in Q1 2023, an estimated $450K.
  • K.J. Harrison & Partners first reported a position in Beam Therapeutics in Q1 2021 and held it in 8 quarters.
  • K.J. Harrison & Partners's Beam Therapeutics position peaked at $1.87M in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2023.

Based on K.J. Harrison & Partners's 13F filing for Q1 2023, filed 25 Apr 2023.